Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) shares were down 0.5% during mid-day trading on Thursday . The company traded as low as €41.20 ($42.47) and last traded at €41.20 ($42.47). Approximately 46 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 1,927 shares. The stock had previously closed at €41.40 ($42.68).
Biotest Aktiengesellschaft Price Performance
The company has a debt-to-equity ratio of 116.50, a current ratio of 2.45 and a quick ratio of 1.66. The company has a market cap of $815.35 million, a PE ratio of 9.93 and a beta of 0.24. The stock has a fifty day moving average price of €41.46 and a 200-day moving average price of €41.65.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Featured Stories
- Five stocks we like better than Biotest Aktiengesellschaft
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Conference Calls and Individual Investors
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What Are Dividends? Buy the Best Dividend Stocks
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
